Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC PatientsIlaria Grazia Zizzari, Chiara Napoletano, Alessandra Di Filippo et al.|Journal of Personalized Medicine|2020Cited by 44
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with CancerIlaria Grazia Zizzari, Chiara Napoletano, Giovanni Schinzari et al.|Clinical Cancer Research|2022Cited by 30
Supplementary Figure from Circulating CD137<sup>+</sup> T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with CancerIlaria Grazia Zizzari, Chiara Napoletano, Giovanni Schinzari et al.|Unknown|2023Cited by 0
Supplementary Figure from Circulating CD137<sup>+</sup> T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with CancerIlaria Grazia Zizzari, Chiara Napoletano, Lidia Strigari et al.|Unknown|2023Cited by 0